Overview:
Market Research Future (MRFR) in their detailed report on the global Veterinary Pain Management Market expected to register a CAGR of 6.46% during the assessment period of 2020 to 2027, to reach USD 4,582.8 Million by 2027.
Veterinary pain management is a part of the animal care sector where various equipment and medicines are developed to ease the pains of pets and other animals. The market is witnessing significant growth due to the extensive research that is taking place in various countries to come up with best possible counter measures. Major factor that is favoring the market is the increasing per capita income that is ensuring growing pet adoption rate. Cost-effective veterinary treatment is also another factor that can provide substantial tailwind to the market. Relentless works done by PETA and WHO are also triggering market expansion. But it can witness some setbacks due to lack of awareness among the commoners regarding pet healthcare.
Segmentation:
MRFR, to aide their study and users has segmented the global veterinary pain management market by drug type, devices, route of administration, animal type, application, and end-user.
Based on the drug type, the veterinary pain management market is segmented into nonsteroidal anti-inflammatory drugs, opioids, local anesthetics, α2-adrenergic agonists, muscle relaxants, sedatives, and corticosteroids. Nonsteroidal anti-inflammatory drugs include etodolac, fentanyl, and meloxicam. Opioids comprises morphine, hydromorphone, codeine, and others. Local anesthetics consists bupivacaine, lidocaine, chloroprocaine, and others. α2-adrenergic agonists are further segmented into xylazine, medetomidine, and others. By devices, the market can be sub-segmented into laser therapy devices and electromagnetic therapy devices.
On the basis of the route of administration, the veterinary pain management market comprises oral, parenteral, and topical.
Based on the animal type, the veterinary pain management market can be segmented into companion animals, livestock, research animals, aquatic animals, zoo animals, and exotic animals.
Application-wise, the veterinary pain management market is segmented into joint pain, postoperative pain, and cancer.
Based on the end-user, the veterinary pain management market includes veterinary hospitals and clinics, research institutes and universities, and laboratories.
Regional Analysis:
MRFR segments the veterinary pain management market into four regions North America, Europe, Asia Pacific (APAC), and Middle East and Africa (MEA).
North America is leading the charge with a wide-range of animal care products, and with special emphasis on animal health. The region also has stringent government regulations to eliminate malpractice. In addition, advanced technologies are sufficiently providing tailwind to latest innovation by enabling research and development sector with in-depth study. Factors such as these are playing pivotal in market growth. Countries such as Canada and the U.S. are expanding their market by exporting exporting surgical equipment and surgical suturing material across the world. Besides, veterinary hospitals are also increasing in numbers which is further fueling market growth.
Increasing pet ownership is the reason behind Europe’s growth as a market and it further benefiting from the tax benefits granted by governments. European countries like Germany, France, and the U.K, are witnessing expenditure rising high to boost the production of medical and surgical devices.
The APAC is also showing promising signs where countries such as India and China can contribute significantly to the market. Australia and Japan can also turn major contributors. China has the regional dominance, whereas, India can grow with the fastest CAGR during the forecast period.
Competitive Landscape:
Notable players of the veterinary pain management market are Dechra Pharmaceuticals, Zoetis, Ceva Santé Animale, Chanelle, Norbrook Laboratories, Bayer, Merck Animal Health, Elanco, Boehringer Ingelheim, Assisi Animal Health, and Vetoquinol.
In 2018, ACTIVet PRO LaserShower was launched. The product is perfect for larger animals such as horse. It is portable which makes it easier to handle while using it as a therapy on such bigger animals. Laser therapy in last few years have evolved as a good pain-killer and this product is expected to corroborate that belief.
Another medicine, Cerenia is proving to be effective against abdominal pain and nausea. It is increasing the chance of survival of parvo puppies by 40% which is quite exciting.
Read More @ https://www.marketresearchfuture.com/reports/veterinary-pain-management-market-5961
NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact:
Akash Anand
Market Research Future
+1 646 845 9312
Email: sales@marketresearchfuture.com
No comments:
Post a Comment